Keywords: Chugai, Roche, Avastin, Glioblastoma, Japan

Chugai pushed into filing for Avastin glioblastoma indication in Japan

Article | 21 September 2012

Print This

Japanese drugmaker Chugai Pharmaceutical (TYO: 4519), which is majority-owned by Swiss drug major Roche (ROG: SIX), says that it has filed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in